Pharmaceutical manufacturing

This photo provided by Novartis shows their gene therapy medicine Zolgensma. U.S. regulators want to know why Novartis didn't disclose a problem with testing data until after they approved the Swiss drugmaker’s $2.125 million gene therapy. On Tuesday, Aug. 6, 2019, the Food and Drug Administration said the questionable data involves testing of the therapy, Zologensma, on animals, not on patients. (Novartis via AP)
August 06, 2019 - 6:24 pm
TRENTON, N.J. (AP) — U.S. regulators want to know why Novartis didn't disclose a problem with testing data until after the Swiss drugmaker's $2.1 million gene therapy was approved. The Food and Drug Administration said Tuesday the manipulated data involved testing in animals, not patients, and it's...
Read More
Traders Gregory Rowe, left, and Daniel Kryger, center, work with specialist Mario Picone on the floor of the New York Stock Exchange, Tuesday, Aug. 6, 2019. Stock markets turned higher on Tuesday as China stabilized its currency after allowing it to depreciate against the dollar in response to President Donald Trump's decision to put more tariffs on Chinese goods. (AP Photo/Richard Drew)
August 06, 2019 - 5:06 pm
Stocks closed broadly higher Tuesday as Wall Street regained its footing a day after the market had its biggest decline in a year. The bounce pushed the Dow Jones Industrial Average more than 300 points higher and snapped a six-day losing streak for the market, though the benchmark S&P 500...
Read More
FILE - In this Tuesday, July 16, 2019, file photo, Health and Human Services Secretary Alex Azar pauses while speaking during a Cabinet meeting at the White House, in Washington. Azar says he and President Donald Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 10:35 am
WASHINGTON (AP) — The Trump administration said Wednesday it will set up a system allowing Americans to legally and safely import lower-cost prescription drugs from Canada for the first time, reversing years of opposition from federal health authorities amid a public outcry over high prices for...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. Merck & Co., Inc. reports financial results on Tuesday, July 30, 2019. (AP Photo/Seth Wenig, File)
July 30, 2019 - 4:11 pm
Soaring sales of its cancer blockbuster and vaccines helped drive Merck's second-quarter profit up a whopping 54%, blowing past Wall Street expectations. The maker of cancer immunotherapy drug Keytruda and diabetes pill Januvia also benefited from slightly reduced spending on research and...
Read More
FILE - In this July 22, 2019, file photo trader William Lawrence works on the floor of the New York Stock Exchange. U.S. stocks moved lower in early trading on Wall Street Monday, July 29, as investors pulled back after pushing stocks to record highs last week. (AP Photo/Richard Drew, File)
July 29, 2019 - 4:54 pm
Major U.S. stock indexes closed mostly lower Monday as investors turned cautious ahead of a key Federal Reserve interest policy announcement and other potentially market-moving developments on tap for this week. Banks, retailers and communications companies took the brunt of the selling. Those...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 4:26 pm
SACRAMENTO, Calif. (AP) — Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. A prescription drug compromise that would lower costs for Medicare recipients has cleared a key hurdle in the Senate, but Republican resistance signals trouble when the legislation goes to the floor. (AP Photo/Elise Amendola, File)
July 25, 2019 - 8:15 pm
WASHINGTON (AP) — A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday, but Republican resistance signaled trouble as the legislation faces floor consideration. The Finance Committee...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. Two senior senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs that serve seniors and low-income people. (AP Photo/Elise Amendola)
July 23, 2019 - 7:19 pm
WASHINGTON (AP) — Two veteran senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs serving seniors and low-income people. Iowa Republican...
Read More
FILE- This Nov. 14, 2018, file photo shows Lubriderm, a Johnson & Johnson product, on display at a market in Pittsburgh. Johnson & Johnson reports financial results on Tuesday, July 16. (AP Photo/Gene J. Puskar, File)
July 16, 2019 - 8:18 am
Johnson & Johnson posted slightly lower sales across much of its business in the second quarter, but a big one-time gain and lower spending on marketing and administration boosted its profit a whopping 42 percent. That blew past Wall Street expectations. The maker of baby shampoo and cancer and...
Read More
FILE - In this June 6, 2019, file photo specialist John Parisi, left, works with traders on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Friday, July 12. (AP Photo/Richard Drew, File)
July 12, 2019 - 3:29 pm
NEW YORK (AP) — U.S. stocks were modestly higher in afternoon trading on Friday, as declines in health care stocks were offset by gains in technology, consumer discretionary and industrial company stocks. The gains came a day after the Dow Jones Industrial Average closed above 27,000 points for the...
Read More

Pages